Lipid‐Free Apolipoprotein A‐I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio

Lipid‐Free Apolipoprotein A‐I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio

BackgroundAtherosclerosis is a chronic inflammatory disorder whose development is inversely correlated with high‐density lipoprotein concentration. Current therapies involve pharmaceuticals that significantly elevate plasma high‐density lipoprotein cholesterol concentrations. Our studies were conduc...

Full description

Bibliographic Details
Main Authors:	Sushma Kaul, Hao Xu, Manal Zabalawi, Elisa Maruko, Brian E. Fulp, Theresa Bluemn, Kristina L. Brzoza‐Lewis, Mark Gerelus, Ranjuna Weerasekera, Rachel Kallinger, Roland James, Yi (Sherry) Zhang, Michael J. Thomas, Mary G. Sorci‐Thomas
Format:	Article
Language:	English
Published:	Wiley 2016-10-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	apolipoprotein apolipoprotein A‐I cholesterol chronic inflammation high‐density lipoprotein inflammation
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.116.004401

Similar Items

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
by: Brian J. Van Lenten, et al.
Published: (2007-11-01)

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
by: C. Roger White, et al.
Published: (2014-10-01)

Extracellular cholesterol-rich microdomains generated by human macrophages and their potential function in reverse cholesterol transport
by: Daniel S. Ong, et al.
Published: (2010-08-01)

Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity[S]
by: Tomáš Vaisar, et al.
Published: (2015-08-01)

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
by: Kuo-Liong Chien, et al.
Published: (2007-11-01)

Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells
by: John K. Bielicki, et al.
Published: (1999-01-01)

Looking Beyond LDL-Cholesterol - A Study on Extended Lipid Profile in Indian Patients with Acute Coronary Syndrome
by: Naveen Kumar, et al.
Published: (2019-11-01)

Role of glutamic acid residues 154, 155, and 165 of lecithin:cholesterol acyltransferase in cholesterol esterification and phospholipase A2 activities
by: Jingchuan Wang, et al.
Published: (1998-01-01)

ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease
by: Cinzia Marchi, et al.
Published: (2019-08-01)

Reconfiguring Nature’s Cholesterol Accepting Lipoproteins as Nanoparticle Platforms for Transport and Delivery of Therapeutic and Imaging Agents
by: Skylar T. Chuang, et al.
Published: (2020-05-01)

Cholesterols, Apolipoproteins, and Their Associations with the Presence and Severity of Diabetic Retinopathy: A Systematic Review
by: Soefiandi Soedarman, et al.
Published: (2022-12-01)

VNN1 promotes atherosclerosis progression in apoE−/− mice fed a high-fat/high-cholesterol diet
by: Yan-Wei Hu, et al.
Published: (2016-08-01)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
by: Tamara Glavinovic, et al.
Published: (2022-10-01)

Apolipoprotein C3: form begets function
by: Karin E. Bornfeldt
Published: (2024-01-01)

Apolipoprotein B is associated with CT-angiographic progression beyond low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in patients with coronary artery disease
by: Xing Shui, et al.
Published: (2023-08-01)

Relationship between Apolipoprotein Superfamily and Parkinson's Disease
by: Lin Li, et al.
Published: (2017-01-01)

The ratio of low-density lipoprotein cholesterol to apolipoprotein-B as a marker of low-density lipoprotein particle size
by: A. M. Kaneva, et al.
Published: (2018-06-01)

Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects
by: Philippe N. Duchateau, et al.
Published: (2000-08-01)

Apolipoprotein B/A1 Ratio as a Diagnostic Alternative to Triglycerides and HDL-Cholesterol for the Prediction of Metabolic Syndrome among Hypertensives in Kazakhstan
by: Alma Nurtazina, et al.
Published: (2020-07-01)

Association of sleep duration with apolipoproteins and the apolipoprotein B/A1 ratio: the China health and nutrition survey
by: Huihui Ren, et al.
Published: (2018-01-01)

Hepatic apolipoprotein A-I gene expression in patients with cholesterol gallstones treated with ursodeoxycholic acid
by: Nahum Méndez-Sánchez, et al.
Published: (2002-04-01)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
by: Günther Silbernagel, et al.
Published: (2022-06-01)

Effect of Lactobacillus delbrueckii on cholesterol metabolism in germ-free mice and on atherogenesis in apolipoprotein E knock-out mice
by: L.R. Portugal, et al.
Published: (2006-05-01)

Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia
by: Wenwang Rao, et al.
Published: (2021-12-01)

Apolipoprotein M promotes cholesterol uptake and efflux from mouse macrophages
by: Shuang Yao, et al.
Published: (2021-06-01)

Helical domains that mediate lipid solubilization and ABCA1-specific cholesterol efflux in apolipoproteins C-I and A-II[S]
by: Loren E. Smith, et al.
Published: (2013-07-01)

PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease
by: Bianca Papotti, et al.
Published: (2022-10-01)

Decreased postprandial high density lipoprotein cholesterol and apolipoproteins A-I and E in normolipidemic smoking men: relations with lipid transfer proteins and LCAT activities
by: N. Mero, et al.
Published: (1998-07-01)

Apolipoprotein E deficiency potentiates macrophage against Staphylococcus aureus in mice with osteomyelitis via regulating cholesterol metabolism
by: Mincheng Lu, et al.
Published: (2023-07-01)

Apple procyanidins decrease cholesterol esterification and lipoprotein secretion in Caco-2/TC7 enterocytes
by: Romain Vidal, et al.
Published: (2005-02-01)

Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness
by: Geyue Qu, et al.
Published: (2021-07-01)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
by: Bi-lian Yu, et al.
Published: (2012-09-01)

Cholesterol
by: Robert L. Raffaï, et al.
Published: (2003-08-01)

Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation
by: Laura Bouchareychas, et al.
Published: (2018-05-01)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
by: Allan D. Sniderman, et al.
Published: (2016-10-01)

Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
by: Xianglan eYao, et al.
Published: (2012-03-01)

Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis
by: Azevedo Orleâncio Gomes R, et al.
Published: (2012-07-01)

Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
by: Wang Pan, et al.
Published: (2020-05-01)

Cholesterol Regulates Exosome Release in Cultured Astrocytes
by: Mohammad Abdullah, et al.
Published: (2021-10-01)

α-Synuclein Regulates Neuronal Cholesterol Efflux
by: Jen-Hsiang T. Hsiao, et al.
Published: (2017-10-01)